RAFAEL HOLDINGS, INC. Accounts Payable and Accrued Liabilities, Noncurrent
RAFAEL HOLDINGS, INC. (RFL) had Accounts Payable and Accrued Liabilities, Noncurrent of $3.48 million as of 2026-01-31, per its 10-Q filed 2026-03-16.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent · last filed 2026-06-11
- 2026-01-31: Accounts Payable and Accrued Liabilities, Noncurrent $3.48M.
- 2025-10-31: Accounts Payable and Accrued Liabilities, Noncurrent $3.90M.
- 2025-07-31: Accounts Payable and Accrued Liabilities, Noncurrent $3.90M.
- 2025-04-30: Accounts Payable and Accrued Liabilities, Noncurrent $3.40M.
| Period end | Accounts Payable and Accrued Liabilities, Noncurrent | Accounts Payable and Accrued Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-01-31 | $3.48M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $3.90M 10-Q · filed 2025-12-12 | |
| 2025-07-31 | $3.90M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | $3.40M 10-Q · filed 2025-06-11 | |
| 2025-01-31 | $3.30M 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $3.10M 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $2.98M 10-K · filed 2025-10-29 | $3.00M 10-K · filed 2024-11-07 |
| 2024-04-30 | $2.80M 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |